Carson Allaria Wealth Management, Ltd. Abb Vie Inc. Transaction History
Carson Allaria Wealth Management, Ltd.
- $169 Million
- Q3 2024
A detailed history of Carson Allaria Wealth Management, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Carson Allaria Wealth Management, Ltd. holds 129 shares of ABBV stock, worth $23,367. This represents 0.01% of its overall portfolio holdings.
Number of Shares
129
Previous 128
0.78%
Holding current value
$23,367
Previous $21,000
19.05%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
3,849Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$31.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$24.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$14.3 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.44 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$7.01 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $320B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...